ZA912837B - Synthetic poly-ig receptor,receptor-antibody complexes,production and use thereof - Google Patents

Synthetic poly-ig receptor,receptor-antibody complexes,production and use thereof

Info

Publication number
ZA912837B
ZA912837B ZA912837A ZA912837A ZA912837B ZA 912837 B ZA912837 B ZA 912837B ZA 912837 A ZA912837 A ZA 912837A ZA 912837 A ZA912837 A ZA 912837A ZA 912837 B ZA912837 B ZA 912837B
Authority
ZA
South Africa
Prior art keywords
receptor
poly
production
disclosed
methods
Prior art date
Application number
ZA912837A
Other languages
English (en)
Inventor
Jean-Pierre Kraehenbuhl
Kraehenbuhl Jean-Pierre
Richard A Weltzin
A Weltzin Richard
Marian R Neutra
R Neutra Marian
Original Assignee
Harvard College
Inst Swisse De Rech Expertment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Inst Swisse De Rech Expertment filed Critical Harvard College
Publication of ZA912837B publication Critical patent/ZA912837B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA912837A 1990-04-16 1991-04-16 Synthetic poly-ig receptor,receptor-antibody complexes,production and use thereof ZA912837B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51016190A 1990-04-16 1990-04-16

Publications (1)

Publication Number Publication Date
ZA912837B true ZA912837B (en) 1992-03-25

Family

ID=24029610

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912837A ZA912837B (en) 1990-04-16 1991-04-16 Synthetic poly-ig receptor,receptor-antibody complexes,production and use thereof

Country Status (21)

Country Link
EP (1) EP0480014B1 (da)
JP (1) JPH05501118A (da)
KR (1) KR920702625A (da)
CN (1) CN1057785A (da)
AT (1) ATE145137T1 (da)
AU (2) AU7792691A (da)
BG (1) BG95634A (da)
BR (1) BR9105717A (da)
CA (1) CA2059289A1 (da)
DE (1) DE69123121T2 (da)
DK (1) DK0480014T3 (da)
ES (1) ES2097207T3 (da)
FI (1) FI915881A7 (da)
GR (1) GR3022512T3 (da)
HU (1) HUT63059A (da)
NO (1) NO914946L (da)
OA (1) OA09647A (da)
RO (1) RO109703B1 (da)
RU (1) RU2124050C1 (da)
WO (1) WO1991016061A1 (da)
ZA (1) ZA912837B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
WO1994014475A1 (en) * 1992-12-21 1994-07-07 Tanox Biosystems, Inc. ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
US6808709B1 (en) 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
DE69535557T2 (de) * 1994-12-30 2008-04-30 Planet Biotechnology, Inc., San Diego Verfahren zur herstellung von schutzproteine enthaltende immunoglobuline und ihre verwendung
EP0839915A1 (en) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Secretory immunoglobulin A as a mucosal vaccine delivery system
CA2407426A1 (en) 2000-04-28 2001-11-08 Planet Biotechnology, Inc. Immunoadhesin for the prevention of rhinovirus infection
MXPA02011092A (es) 2000-05-10 2004-08-19 David A Sirbasku Composiciones y metodos para demostrar la regulacion del sistema inmune secretor del crecimiento de la celula de cancer que responde a la hormona esteroidea.
RU2186390C1 (ru) * 2001-01-26 2002-07-27 Научно-исследовательский институт эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Способ выделения пневмоцист
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
CN104903727B (zh) * 2012-11-08 2019-10-22 马克法兰伯尼特医学研究与公共健康协会有限公司 诊断、预后、治疗和筛选方案
RU2605321C1 (ru) * 2015-07-16 2016-12-20 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Фракция днк-гидролизующих секреторных иммуноглобулинов класса а, обладающая избирательной апоптотической активностью по отношению к раковым клеткам человека

Also Published As

Publication number Publication date
HUT63059A (en) 1993-07-28
CN1057785A (zh) 1992-01-15
WO1991016061A1 (en) 1991-10-31
JPH05501118A (ja) 1993-03-04
RO109703B1 (ro) 1995-05-30
CA2059289A1 (en) 1991-10-17
NO914946L (no) 1992-02-12
BR9105717A (pt) 1992-07-21
DK0480014T3 (da) 1997-02-17
BG95634A (bg) 1993-12-24
GR3022512T3 (en) 1997-05-31
AU7792691A (en) 1991-11-11
EP0480014B1 (en) 1996-11-13
HU9200136D0 (en) 1992-04-28
RU2124050C1 (ru) 1998-12-27
OA09647A (en) 1993-04-30
KR920702625A (ko) 1992-10-06
AU7771594A (en) 1995-04-06
FI915881A0 (fi) 1991-12-13
ES2097207T3 (es) 1997-04-01
ATE145137T1 (de) 1996-11-15
EP0480014A1 (en) 1992-04-15
AU687443B2 (en) 1998-02-26
FI915881A7 (fi) 1991-12-13
NO914946D0 (no) 1991-12-13
EP0480014A4 (en) 1992-10-14
DE69123121D1 (de) 1996-12-19
DE69123121T2 (de) 1997-04-03

Similar Documents

Publication Publication Date Title
ZA912837B (en) Synthetic poly-ig receptor,receptor-antibody complexes,production and use thereof
DE69023900T4 (de) Gentechnologisch veränderte immunglobuline.
EP0571613A4 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
CA2290485A1 (en) Method for the production of non-immunogenic proteins
EP1476120A4 (en) THERAPEUTIC METHODS USING ANTI-CD22 ANTIBODIES
ES2147558T3 (es) Nuevos polipeptidos para promover la fijacion celular.
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
EP0857489A3 (en) Production and use of multimeric hemoglobins
DK0606217T3 (da) CTL4-receptor,fusionsproteiner indeholdende den samt anvendelse deraf
IL114668A0 (en) Htk ligand
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
ATE238065T1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
DE10299038I1 (de) Plaettchen-Spezifisches Chimaerisches Immunglobulin
EP0493446A4 (en) Treatment of autoimmune disease
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
WO1996023884A3 (en) Human peroxisome proliferator activated receptors
DE69020914D1 (de) Monoklonale Antikörper von Ratten gegen menschliche Antigene und Verfahren zu deren Herstellung.
DE60123063T2 (de) Peptid-fruktose und ein komplex davon mit bindendem protein
Iwata et al. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.